A detailed history of Hartford Investment Management CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Hartford Investment Management CO holds 10,562 shares of TEVA stock, worth $184,835. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,562
Previous 10,511 0.49%
Holding current value
$184,835
Previous $170,000 11.76%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$15.81 - $18.96 $806 - $966
51 Added 0.49%
10,562 $190,000
Q2 2024

Aug 01, 2024

BUY
$12.78 - $17.4 $2,300 - $3,131
180 Added 1.74%
10,511 $170,000
Q1 2024

Apr 17, 2024

BUY
$10.67 - $14.43 $106 - $144
10 Added 0.1%
10,331 $145,000
Q3 2023

Oct 16, 2023

BUY
$7.48 - $10.7 $1,525 - $2,182
204 Added 2.02%
10,321 $105,000
Q2 2023

Jul 19, 2023

BUY
$7.2 - $9.47 $72,842 - $95,807
10,117 New
10,117 $76,000
Q2 2022

Jul 22, 2022

SELL
$7.38 - $10.4 $154 - $218
-21 Reduced 0.16%
13,006 $98,000
Q1 2022

Apr 20, 2022

SELL
$7.33 - $9.39 $51,925 - $66,518
-7,084 Reduced 35.22%
13,027 $122,000
Q4 2021

Feb 02, 2022

SELL
$7.9 - $10.19 $1,335 - $1,722
-169 Reduced 0.83%
20,111 $161,000
Q3 2021

Nov 01, 2021

SELL
$8.38 - $10.18 $25,517 - $30,998
-3,045 Reduced 13.05%
20,280 $198,000
Q2 2021

Jul 29, 2021

SELL
$9.9 - $11.56 $4,286 - $5,005
-433 Reduced 1.82%
23,325 $231,000
Q1 2021

Apr 21, 2021

SELL
$10.34 - $12.81 $25,653 - $31,781
-2,481 Reduced 9.46%
23,758 $274,000
Q4 2020

Feb 01, 2021

SELL
$8.61 - $11.04 $77 - $99
-9 Reduced 0.03%
26,239 $253,000
Q3 2020

Oct 29, 2020

SELL
$8.57 - $12.69 $5,990 - $8,870
-699 Reduced 2.59%
26,248 $236,000
Q2 2020

Aug 04, 2020

BUY
$8.12 - $13.12 $1,859 - $3,004
229 Added 0.86%
26,947 $332,000
Q1 2020

Apr 24, 2020

BUY
$6.69 - $13.45 $2,789 - $5,608
417 Added 1.59%
26,718 $240,000
Q4 2019

Jan 29, 2020

SELL
$6.53 - $10.72 $10,043 - $16,487
-1,538 Reduced 5.52%
26,301 $258,000
Q3 2019

Oct 28, 2019

SELL
$6.16 - $9.6 $2,987 - $4,656
-485 Reduced 1.71%
27,839 $192,000
Q2 2019

Jul 25, 2019

BUY
$8.12 - $15.72 $14,193 - $27,478
1,748 Added 6.58%
28,324 $261,000
Q1 2019

Apr 29, 2019

SELL
$15.58 - $20.01 $46,817 - $60,130
-3,005 Reduced 10.16%
26,576 $417,000
Q4 2018

Feb 04, 2019

BUY
$14.59 - $23.84 $13,160 - $21,503
902 Added 3.15%
29,581 $456,000
Q3 2018

Nov 08, 2018

SELL
$21.06 - $25.65 $24,219 - $29,497
-1,150 Reduced 3.86%
28,679 $618,000
Q2 2018

Jul 19, 2018

BUY
$16.77 - $24.71 $29,464 - $43,415
1,757 Added 6.26%
29,829 $725,000
Q1 2018

Apr 24, 2018

SELL
$16.68 - $22.07 $49,739 - $65,812
-2,982 Reduced 9.6%
28,072 $480,000
Q4 2017

Feb 12, 2018

SELL
$11.23 - $19.1 $1,145 - $1,948
-102 Reduced 0.33%
31,054 $588,000
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $480,113 - $1 Million
31,156
31,156 $548,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.